-
Villa put six past Fenerbahce in record rout
-
In Chicago, pope's hometown, Catholics express shock and support
-
US stocks fall after hot inflation report as leading AI shares tumble
-
Musk suggests US govt behind any slowdown in Ukraine's Starshield system
-
Government buildings torched in violent Albanian protests
-
Chiclayo prays for recovery and return of the 'Peruvian pope'
-
Wall Street grills Bank of America over money laundering fine
-
Barcola scores hat-trick as Liverpool hit LASK for six
-
Mekies extends contract as Red Bull team principal until 2031
-
Healthy corals help bleached neighbors regain color: study
-
Indonesia rescues starved orangutan from fires: officials
-
Hope ton helps West Indies level T20 series at 2-2 in India
-
Real Madrid's Vinicius banned for Clasico after red card
-
Ukraine war reaches shores of Bulgarian fishing village
-
Restrictions expose Ukraine's Starlink dependency in Russia war: observers
-
Brazil probing 'criminal' origin of forest fires: minister to AFP
-
Espada out as Astros manager while Mattingly stays with Phillies
-
Sally Rooney books cannot be sold in UK amid Palestine Action ban: publisher
-
Houthis say targeted Saudi oil giant Aramco, vow more attacks
-
Italian ski stars Goggia and Brignone to miss season opener
-
Govt takes control of Turkey's most-watched news channel
-
Bournemouth boss Rose urges Cherries to bounce back from Chelsea 'slap'
-
FIFA to offer members $6.35-billion development fund windfall
-
Top seed Sabalenka falls at first hurdle in Wuhan
-
US consumer inflation hotter than expected as midterms loom
-
FX Junction Brings Copy Trading to Everyone, While Their Money Never Leaves With Their Broker
-
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro
-
Brighton defender Struijk's red card overturned
-
Hot US inflation data dents Wall Street stocks
-
Saudi league postpones three matches after Houthi attacks
-
India sends 'cockroach' leaders to jail after protest
-
US consumer inflation up more than expected as midterms loom
-
'Sinners' director Ryan Coogler to reboot 'X-Files' for Disney
-
Canadian publisher supports novelist Orelien after AI denial
-
Lufthansa wins contest for TAP Air Portugal stake
-
Medvedev sees off Tsitsipas to reach Shanghai Masters quarters
-
AI worms, 'major' incident fears spur safety calls at industry summit
-
Louvre boss warns of closure risk without major renovations
-
Fuel shortage triggers queues on Indonesia's Bali island
-
Lawes and Genge urge England to end ban on overseas-based players
-
Evolution Metals & Technologies Corp. Reaffirms $400 Million to $460 Million FY2027 Revenue Guidance, Unveils Eight Sintered Magnet Grades Covering an Estimated 75% of Global NdFeB Revenue, and Moves to Answer U.S. Army Call for Rare Earth Magnets
-
Metrika Selected by OCC to Support Stablecoin Supervisory Framework Under the GENIUS Act
-
Trial defence says Russia used Nord Stream pipelines as 'weapon'
-
Kenya hosting 2029 World Championships will help doping fight, says Coe
-
Israeli settlers set fire to mosque in occupied West Bank
-
UK prosecutor tells jury Russell Brand a 'sexual predator'
-
Macron says French student protesters 'exploited' by political forces: spokeswoman
-
Fulham manager Arbeloa fined £25,000 after Man Utd outburst
-
Stocks diverge ahead of key US inflation data
-
Nepal flood triggered by rock and ice avalanche: report
WHO says clinical trials soon for Ebola virus in Uganda
World Health Organization chief Tedros Adhanom Ghebreyesus said Wednesday that clinical trials could start within weeks on vaccines to combat the strain of Ebola behind a deadly outbreak in Uganda.
Kampala last month announced Uganda's first fatality from the highly contagious disease since 2019, with Health Minister Jane Ruth Aceng on Wednesday giving a death toll of "over 19" including several health workers.
There is currently no vaccine for the Sudan ebola virus circulating in the East African country.
"Unfortunately, the Ebola vaccines that have been so effective in controlling recent outbreaks in DRC (Democratic Republic of Congo) are not effective against the type of ebola virus which is responsible for the current outbreak in Uganda," Tedros told a regional ministerial meeting to discuss the emergency response to the crisis.
"Several vaccines are in various stages of development against this virus, two of which could begin clinical trials in Uganda in the coming weeks, pending regulatory and ethics approvals from the Ugandan government."
Tedros, who spoke to the meeting from Geneva, reported 54 confirmed and 20 probable cases, while more than 660 contacts are currently under "active follow-up".
The initial outbreak, which was first reported on September 20, was discovered in Uganda's central district of Mubende, and infections have been found in four other areas.
"Our primary focus now is to support the government of Uganda to rapidly control and contain this outbreak, to stop it spreading to neighbouring districts, and neighbouring countries," Tedros told reporters.
A WHO assessment has found the risk of the Sudan ebola virus spreading to neighbouring countries was "high due to cross border movements between Uganda and other countries".
Ebola is an often-fatal viral haemorrhagic fever named after a river in DR Congo where it was discovered in 1976.
Human transmission is through bodily fluids, with common symptoms fever, vomiting, bleeding and diarrhoea. Outbreaks are difficult to contain, especially in urban environments.
People who are infected do not become contagious until symptoms appear, which is after an incubation period of between two and 21 days.
The worst epidemic in West Africa between 2013 and 2016 killed more than 11,300 people.
Uganda has experienced several Ebola outbreaks, most recently in 2019 when at least five people died. The neighbouring DRC has had more than a dozen epidemics, the deadliest killing 2,280 people in 2020.
Last week the United States announced tighter screening for people who had travelled to Uganda.
O.Salim--SF-PST